Influenza Vaccination in Immunocompromized Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00783380
Recruitment Status : Completed
First Posted : October 31, 2008
Last Update Posted : November 3, 2008
Boehringer Ingelheim
Merck Sharp & Dohme Corp.
Solvay Pharmaceuticals
Information provided by:
University Hospital Inselspital, Berne

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2006
  Actual Study Completion Date : March 2008

Publications automatically indexed to this study by Identifier (NCT Number):